Ribosomal protein L23a pseudogene 23 (RPL23AP23)

Ribosomal protein L23a pseudogene 23 (RPL23AP23) is one of many processed pseudogenes derived from the ribosomal protein L23a gene (RPL23A)[1][3]. Pseudogenes are generally non-coding DNA segments originating from ancestor protein-coding genes, often unable to produce functional proteins due to accumulated mutations. While a few ribosomal protein L23a pseudogenes have been studied for potential regulatory or biomarker roles in cancer (notably RPL23AP53 in melanoma), there is no experimental or clinical data identifying any specific biological or pathological function for RPL23AP23[1][5]. It is not a member of typical molecular target families (e.g., receptor, enzyme, transporter) nor described as implicated in human disease or targeted by any known drugs.

Other names

RPL23A_5_178RPL23AP23

None described, as it is not a functional protein or classic drug target